Comment on 'De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine': possible role for Type I interferons.
作者信息
Awada B, Abdullah L, Kurban M, Abbas O
机构信息
Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon.
出版信息
Clin Exp Dermatol. 2022 Feb;47(2):443. doi: 10.1111/ced.14941. Epub 2021 Oct 5.
Abstract
摘要
相似文献
1
Comment on 'De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine': possible role for Type I interferons.关于《牛津-阿斯利康新冠疫苗接种后新发泛发性脓疱型银屑病：I型干扰素的可能作用》的评论
Clin Exp Dermatol. 2022 Feb;47(2):443. doi: 10.1111/ced.14941. Epub 2021 Oct 5.
2
De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.接种牛津-阿斯利康新冠疫苗后新发泛发性脓疱型银屑病。
Clin Exp Dermatol. 2022 Jan;47(1):153-155. doi: 10.1111/ced.14895. Epub 2021 Sep 30.
3
Comment on 'Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?': Type I interferons as possible link between COVID-19 vaccine and vitiligo.关于“一名接种新冠疫苗的溃疡性结肠炎患者出现白癜风：巧合？”的评论：I型干扰素可能是新冠疫苗与白癜风之间的联系。
Clin Exp Dermatol. 2022 Feb;47(2):436-437. doi: 10.1111/ced.14932. Epub 2021 Oct 5.
4
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
5
Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.对牛津-阿斯利康疫苗的安全性担忧后，对 COVID-19 疫苗的持续意愿。
Dan Med J. 2021 Mar 31;68(5):A03210292.
6
Coronavirus disease 2019 vaccination in patients with psoriasis: A position statement from India by SIG psoriasis (IADVL Academy).2019 年冠状病毒病疫苗接种在银屑病患者中的应用：印度皮肤科医师协会（IADVL 学院）的立场声明。
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(3):286-290. doi: 10.25259/IJDVL_773_2021.
7
Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.牛津-阿斯利康新冠疫苗诱发的急性局限性发疹性脓疱病
J Dermatol. 2021 Nov;48(11):e562-e563. doi: 10.1111/1346-8138.16138. Epub 2021 Sep 6.
8
Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine.接种第一剂阿斯利康新型冠状病毒肺炎疫苗后银屑病病情加重。
J Dermatol. 2021 Nov;48(11):e566-e567. doi: 10.1111/1346-8138.16137. Epub 2021 Sep 6.
9
SARS-CoV-2 vaccination and practical points in psoriasis patients: A narrative review.SARS-CoV-2 疫苗接种与银屑病患者的实际问题：叙述性综述。
Dermatol Ther. 2022 May;35(5):e15430. doi: 10.1111/dth.15430. Epub 2022 Mar 22.
10
Oxford-AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign.牛津大学-阿斯利康新冠疫苗：需要一场合理且有效的疫苗接种运动。
Public Health. 2021 Jul;196:135-137. doi: 10.1016/j.puhe.2021.05.030. Epub 2021 Jun 2.
引用本文的文献
1
Current status of generalized pustular psoriasis: Findings from a multicenter hospital-based survey of 127 Chinese patients.泛发性脓疱型银屑病的现状：基于127例中国患者的多中心医院调查结果
Chin Med J (Engl). 2025 Apr 20;138(8):953-961. doi: 10.1097/CM9.0000000000003494. Epub 2025 Mar 17.
2
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks.使用司库奇尤单抗治疗新型冠状病毒肺炎后出现严重银屑病发作：16周后皮肤完全清除。
Dermatol Reports. 2023 Jun 6;16(1):9722. doi: 10.4081/dr.2023.9722. eCollection 2024 Mar 12.
3
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo.白癜风样皮损与新型冠状病毒肺炎：病例报告及疫苗接种和感染相关白癜风的综述
Vaccines (Basel). 2022 Sep 30;10(10):1647. doi: 10.3390/vaccines10101647.
4
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review.新型冠状病毒疫苗接种后银屑病的新发和恶化：系统评价。
Am J Clin Dermatol. 2022 Nov;23(6):775-799. doi: 10.1007/s40257-022-00721-z. Epub 2022 Sep 1.
5
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab.一名斑块状银屑病患者在接种BNT162b2 mRNA新冠疫苗后出现泛发性脓疱型银屑病发作，使用司库奇尤单抗成功治疗。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e502-e505. doi: 10.1111/jdv.18032. Epub 2022 Mar 3.
本文引用的文献
1
De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.接种牛津-阿斯利康新冠疫苗后新发泛发性脓疱型银屑病。
Clin Exp Dermatol. 2022 Jan;47(1):153-155. doi: 10.1111/ced.14895. Epub 2021 Sep 30.
2
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗：免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
3
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.SARS-CoV-2 通过 UNC93B 和 IRAK4 诱导人类浆细胞前树突状细胞多样化。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20201387.
4
IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis.IL-36 促进银屑病严重形式的全身 IFN-I 反应。
J Invest Dermatol. 2020 Apr;140(4):816-826.e3. doi: 10.1016/j.jid.2019.08.444. Epub 2019 Sep 17.
5
Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases.浆细胞样树突状细胞在炎症性/自身免疫性皮肤病中作用的最新进展。
Exp Dermatol. 2016 Jun;25(6):415-21. doi: 10.1111/exd.12957. Epub 2016 Apr 12.
Zotero 插件